KORU Medical Systems, Inc.KRMDNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 80% recommend buying.

Consensus Rating

Buy

5 analysts·Limited coverage

80%

Rating Distribution

Strong Buy

00%

Buy

480%

Hold

120%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 24% higher.

Bear Case

$6.00

+7%

Consensus

$7.00

+24%

Bull Case

$8.00

+42%

Price Range5 analysts

Low

Consensus

High

$6.00

$8.00

Current Target

Current Price

$5.63

Upside to Target

$1.37

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.02(3 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+17.08%

EPS—

Earnings Surprises

Beat rate:25%(3/12 quarters)

Avg surprise:-6.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 13, 2026Craig-Hallum

Koru Medical price target raised to $7 from $6.25 at Craig-Hallum

Target:$7.00

+21.7%from $5.75

Dec 22, 2025Lake Street

Koru Medical price target raised to $8 from $6 at Lake Street

Target:$8.00

+32.7%from $6.03

Dec 17, 2025Canaccord Genuity

Koru Medical price target raised to $6 from $5 at Canaccord

Target:$6.00

+4.0%from $5.77

Nov 14, 2024Piper Sandler

Koru Medical Systems Inc. (KRMD) PT Raised to $3.50 at Piper Sandler

Target:$3.50

+13.1%from $3.10

Jul 2, 2024Canaccord Genuity

Canaccord Genuity Bullish on Koru Medical Systems Inc. (KRMD)

Target:$3.00

+33.3%from $2.25

Jan 6, 2023Piper Sandler

Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5

Target:$4.50

+21.6%from $3.70

May 5, 2022Piper Sandler

Koru Medical investment spend to remain elevated, says Piper Sandler

Target:$3.00

+7.1%from $2.80

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance